StockData
Bicycle Therapeutics PLC logo

Bicycle Therapeutics PLC (BCYC) stock

BCYCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 11/3080% below fair value
$3.20+0.02 (+0.63%)

Close on Nov 17, 2026Market cap $224.30MP/E –Yield 0.00%

Bicycle Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Bicycle Therapeutics's price to book ratio was 0.5× on Nov 11, 2026, against 0.8× a year earlier. Over the last 5 years it ranged from 0.5× to 9.1×, with a median of 1.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.5×−0.3
2025Dec 31, 20250.8×−0.4
2024Dec 31, 20241.2×−0.7
2023Dec 29, 20231.8×−1.2
2022Dec 30, 20223.0×−6.1
2021Dec 31, 20219.1×+5.7
2020Dec 31, 20203.4×+1.7
2019Dec 31, 20191.8×–

More Bicycle Therapeutics figures

See a number that looks wrong?